Editas Medicine, Inc.
EDIT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $132 | $124 | $142 | $204 |
| Short-Term Investments | $138 | $199 | $203 | $296 |
| Receivables | $16 | $10 | $5 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $3 | $8 | $7 | $7 |
| Total Curr. Assets | $289 | $341 | $357 | $507 |
| Property Plant & Equip (Net) | $47 | $46 | $59 | $43 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $104 | $93 | $120 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $5 | $9 | $5 | $7 |
| Total NC Assets | $52 | $158 | $158 | $170 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $342 | $499 | $514 | $677 |
| Liabilities | – | – | – | – |
| Payables | $5 | $8 | $10 | $5 |
| Short-Term Debt | $15 | $24 | $11 | $10 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $11 | $8 | $8 | $11 |
| Other Curr. Liab. | $46 | $23 | $31 | $20 |
| Total Curr. Liab. | $77 | $63 | $60 | $47 |
| LT Debt | $20 | $24 | $33 | $16 |
| Deferred Rev, NC | $107 | $61 | $61 | $61 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $3 | $2 | $0 | $0 |
| Total NC Liab. | $130 | $87 | $94 | $77 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $35 | $37 | $44 | $26 |
| Total Liabilities | $207 | $150 | $154 | $124 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$1,468 | -$1,231 | -$1,078 | -$858 |
| AOCI | $0 | $0 | -$4 | -$0 |
| Other Equity | $1,602 | $1,580 | $1,442 | $1,412 |
| Total Equity | $134 | $349 | $361 | $554 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $342 | $499 | $514 | $677 |
| Net Debt | -$97 | -$75 | -$98 | -$177 |